Abiopharma

🔍 Lockhart Stephen H (Executive)

Company: NRC HEALTH (NRC)

Report Date: 2026-06-23

Detailed Transactions and Holdings:

• Acquired 7,697 shares of Common Stock (Direct)
  Date: 2026-06-23 | Code: A | equity_swap_involved: false | shares_owned_after: 7,697.00 | transaction_form_type: 4 | Footnotes: F1, F1

Footnotes:

• F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.